Premium
D‐cycloserine enhances therapy for anxiety; tailored approach does not improve outcome
Publication year - 2020
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30626
Subject(s) - cycloserine , anxiety , medicine , placebo , randomized controlled trial , exposure therapy , psychotherapist , clinical psychology , physical therapy , psychiatry , psychology , alternative medicine , tuberculosis , pathology
Administration of D‐cycloserine before or after exposure therapy sessions enhanced the therapy's effects compared to placebo in patients with social anxiety disorder, but a tailored approach to D‐cycloserine administration did not result in symptom improvement. The randomized trial's findings were inconsistent with the hypothesis that administering D‐cycloserine only after therapy sessions that were perceived as successful would improve outcomes. Study results were published online June 4, 2020, in JAMA Network Open .